Everolimus-eluting stent implantation versus repeat paclitaxel-coated balloon angioplasty for recurrent in-stent restenosis lesion caused by paclitaxel-coated balloon failure.

@article{Kubo2015EverolimuselutingSI,
  title={Everolimus-eluting stent implantation versus repeat paclitaxel-coated balloon angioplasty for recurrent in-stent restenosis lesion caused by paclitaxel-coated balloon failure.},
  author={Shunsuke Kubo and Kazushige Kadota and Suguru Otsuru and Daiji Hasegawa and Seiji Habara and Takeshi Tada and Hiroyuki Tanaka and Yasushi Fuku and Harumi Katoh and Tsuyoshi Goto and Kazuaki Mitsudo},
  journal={EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology},
  year={2015},
  volume={10 9},
  pages={e1-8}
}
AIMS Although paclitaxel-coated balloon (PCB) angioplasty has been reported to be effective for in-stent restenosis (ISR) lesions, the optimal treatment for recurrent ISR lesions caused by PCB failure remains unclear. This study compared clinical and angiographic outcomes after everolimus-eluting stent (EES) implantation and repeat PCB angioplasty for PCB failure. METHODS AND RESULTS From November 2008 to October 2011, we performed PCB angioplasty for 599 ISR lesions, of which 93 recurrent… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

A novel approach to treat in-stent restenosis: 6- and 12-month results using the everolimus-eluting bioresorbable vascular scaffold.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology • 2016

Similar Papers

Loading similar papers…